Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series

D'Ettorre, G.; Barbarini, G.; Corti, F.; Gobber, M.; Pastecchia, C.; Ricci, G. L.; Siciliano, M.; Annicchiarico, B. E.; Vullo, Vincenzo

We report a case series of three HBeAg positive and five HBeAg negative patients (7 males, mean age 50.6 +/- 14.6 years) with chronic HBV infection experiencing sero-conversion after treatment with entecavir (0.5 mg/day or 1 mg/day), initiated in 2007. Overall, the mean time to HBsAg clearance was 9.4 +/- 4.5 months. Seroconversion occurred in all patients, after a mean time of 8.0 +/- 3.7 months. In HBeAg negative patients, mean time to HBsAg clearance and to seroconversion were 9.2 +/- 5.9 and 6.8 +/- 4.0 months, respectively. In HBeAg positive patients, mean time to HBsAg clearance and to seroconversion were 9.7 +/- 0.6 months and 10.0 +/- 2.6 months, respectively. In this case series, seroconversion was maintained and was observed both in HBeAg positive patients and in HBeAg negative patients. Therefore, it may be preliminarily suggested that treatment with entecavir could be associated to HBsAg seroconversion in a short period of time, in both HBeAg positive and HBeAg negative HBV patients.

Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series / D'Ettorre, G.; Barbarini, G.; Corti, F.; Gobber, M.; Pastecchia, C.; Ricci, G. L.; Siciliano, M.; Annicchiarico, B. E.; Vullo, Vincenzo. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 14:6(2010), pp. 551-554.

Scheda prodotto non validato

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Titolo:	Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series
Autori:	D'ETTORRE, Gabriella G. Barbarini F. Corti M. Gobber C. Pastecchia G. L. Ricci M. Siciliano B. E. Annicchiarico VULLO, Vincenzo mostra contributor esterni nascondi contributor esterni
Data di pubblicazione:	2010
Rivista:	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES
Citazione:	Seroconversion of HBsAg in HBeAg positive and HBeAg negative patients with chronic HBV treated with entecavir: a case series / D'Ettorre, G.; Barbarini, G.; Corti, F.; Gobber, M.; Pastecchia, C.; Ricci, G. L.; Siciliano, M.; Annicchiarico, B. E.; Vullo, Vincenzo. - In: EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES. - ISSN 1128-3602. - 14:6(2010), pp. 551-554.
Handle:	http://hdl.handle.net/11573/417680
Appartiene alla tipologia:	01a Articolo in rivista

File allegati a questo prodotto

Non ci sono file associati a questo prodotto.

Utilizza questo identificativo per citare o creare un link a questo documento:
http://hdl.handle.net/11573/417680

Citazioni

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Catalogo dei prodotti della ricerca

Scheda prodotto non validato

File allegati a questo prodotto